Form 4: Relay Therapeutics CFO Sells Shares
Insider Transaction (Form 4)
Thomas Catinazzo, Chief Financial Officer of Relay Therapeutics, Inc., sold 17,717 shares of common stock on October 6, 2026.
Summary
- Open-market sale: disposed of 17,511 Common Stock at $18.58 ($325,354) on October 6, 2026; holds 105,340 after (Direct).
- Open-market sale: disposed of 206 Common Stock at $19.26 ($3,968) on October 6, 2026; holds 105,134 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $329,322 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Thomas Catinazzo — Officer (Chief Financial Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-06 | Open-market sale | Common Stock | 17,511 | $19 | $325.4K | 105,340 |
| 2026-10-06 | Open-market sale | Common Stock | 206 | $19 | $4.0K | 105,134 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-06 | Open-market sale (17,511 shares) |
| 2026-10-06 | Open-market sale (206 shares) |
Keywords
insider transaction, Form 4, RLAY, Relay Therapeutics, Inc., bearish, Thomas Catinazzo
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.